PAGAN, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 3.068
EU - Europa 2.194
AS - Asia 1.649
SA - Sud America 75
AF - Africa 14
OC - Oceania 12
Totale 7.012
Nazione #
US - Stati Uniti d'America 3.033
SG - Singapore 618
DE - Germania 583
IT - Italia 509
HK - Hong Kong 478
RU - Federazione Russa 404
SE - Svezia 238
CN - Cina 206
IE - Irlanda 170
VN - Vietnam 101
ID - Indonesia 82
BR - Brasile 67
GB - Regno Unito 59
FR - Francia 58
IN - India 42
KR - Corea 33
UA - Ucraina 32
CA - Canada 30
NL - Olanda 25
AT - Austria 21
DK - Danimarca 21
FI - Finlandia 19
JP - Giappone 17
TR - Turchia 12
ES - Italia 11
PK - Pakistan 11
AU - Australia 10
IR - Iran 9
MY - Malesia 8
RO - Romania 7
PL - Polonia 6
BE - Belgio 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
GR - Grecia 4
KG - Kirghizistan 4
TW - Taiwan 4
ZA - Sudafrica 4
AR - Argentina 3
BG - Bulgaria 3
DZ - Algeria 3
IL - Israele 3
MX - Messico 3
PH - Filippine 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BD - Bangladesh 2
EC - Ecuador 2
GH - Ghana 2
HU - Ungheria 2
IQ - Iraq 2
LB - Libano 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RS - Serbia 2
TN - Tunisia 2
BJ - Benin 1
BO - Bolivia 1
CL - Cile 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
JO - Giordania 1
KZ - Kazakistan 1
NG - Nigeria 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
Totale 7.012
Città #
Ann Arbor 818
Frankfurt am Main 511
Hong Kong 474
Singapore 355
Fairfield 259
Wilmington 210
Ashburn 183
Dublin 161
Milan 155
Houston 131
Santa Clara 117
Chandler 116
Seattle 107
New York 98
Woodbridge 94
Princeton 88
Jakarta 82
Cambridge 78
Dearborn 54
Moscow 52
Dong Ket 49
Altamura 45
Lawrence 43
San Diego 40
Shanghai 36
Nanjing 32
Beijing 28
Guangzhou 21
Hefei 21
Nuremberg 20
Seoul 20
Chicago 17
Sacramento 17
Ardea 16
Jacksonville 16
Los Angeles 14
Toronto 14
Andover 13
Munich 12
Naples 12
Seregno 12
Umeå 12
Carate Brianza 11
Mumbai 11
Helsinki 10
London 10
Monza 10
Pune 9
Redmond 9
Vienna 9
Paris 8
Hangzhou 7
Nanchang 7
Pavia 7
Tokyo 7
Ansan-si 6
Boardman 6
Dallas 6
Edmonton 6
Molteno 6
Ottawa 6
Rome 6
Bologna 5
Brussels 5
Busto Arsizio 5
College Station 5
Karachi 5
Kunming 5
Ningbo 5
Norwalk 5
Sorso 5
São Luís 5
Turku 5
Warsaw 5
Atlanta 4
Bau 4
Bishkek 4
Bonndorf 4
Borgosesia 4
Brooklyn 4
Cagliari 4
Florence 4
Gainesville 4
Kota Bharu 4
Marietta 4
Turin 4
Adana 3
Athens 3
Bangkok 3
Bergamo 3
Brescia 3
Changsha 3
Coimbatore 3
Cologno Monzese 3
Fremont 3
Gussago 3
Heilbronn 3
Ho Chi Minh City 3
Huskvarna 3
Islamabad 3
Totale 4.960
Nome #
Joinpoint regression analysis with time-on-study as time-scale. Application to three Italian population-based cohort studies 474
Laryngeal cancer mortality trends in European countries 296
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 227
Sex-based differences of the Tumor mutational burden and T-cell inflammation of the tumor microenvironment 224
Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ 221
Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study 220
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast 211
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers 206
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial 200
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 192
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 192
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 168
Endocrine-responsive lobular carcinoma of the breast: Features associated with risk of late distant recurrence 165
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial 158
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 147
Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes 145
Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” 144
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis 142
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy 140
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up 135
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients 133
Sex-based differences in cancer immunotherapy efficacy 130
Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study 122
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland 122
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 114
Different Response to Immunotherapy According to Melanoma Histologic Subtype 109
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 107
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance? 107
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 106
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer? 100
Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation 99
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy 96
Prognostic impact of baseline immunologic profile in aggressive b-cell non-hodgkin's lymphomas 95
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials 94
How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes 92
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 90
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 89
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment - Authors' reply 87
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations 85
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 81
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer." 79
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 73
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 71
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer 71
Comparison of Trends in Mortality from Coronary Heart and Cerebrovascular Diseases in North and South America: 1980 to 2013 71
Association of prebiotic fiber intake with colorectal cancer risk: the PrebiotiCa study 70
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis 70
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study 65
Pegylated liposomal doxorubicin (Caelyx®) as adjuvant treatment in early-stage luminal b-like breast cancer: A feasibility phase II trial 62
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study 55
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer 54
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center 54
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis 53
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials 52
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 50
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials 49
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis 47
Male breast cancer: a multicenter study to provide a guide for proper management 47
Results of the Italian cross-sectional web-based survey “Nutrition and breast cancer, what would you like to know?” An attempt to collect and respond to patients’ information needs, through social media 47
Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment 47
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 46
Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients 44
Development and Validation of a Natural Language Processing Algorithm for Extracting Clinical and Pathological Features of Breast Cancer From Pathology Reports 41
Comparative Efficacy of Classic Versus Horizontal Incision Techniques in Skin-Reducing Mastectomy: A Single Center Retrospective Analysis 26
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates 11
Totale 7.420
Categoria #
all - tutte 31.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.548


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 0 0 0 0 0 21
2020/20211.093 33 43 78 93 101 136 111 138 69 64 45 182
2021/2022742 81 52 63 33 24 72 33 45 46 79 70 144
2022/20231.251 149 352 172 105 102 185 29 34 24 34 32 33
2023/2024776 18 15 29 72 79 158 106 46 72 40 31 110
2024/20252.519 129 306 135 132 159 138 164 93 296 329 307 331
Totale 7.420